Skip to main content
Yanlin Wang, MD, Nephrology, Farmington, CT

Yanlin Wang MD Ph.D.


Professor and Chief of Nephrology, University of Connecticut School of Medicine

Join to View Full Profile
  • 263 Farmington AvenueMC1405Farmington, CT 06030

  • Phone+1 860-679-2799

Dr. Wang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Yanlin Wang is a nephrologist in Farmington, CT and is affiliated with UConn John Dempsey Hospital. He is experienced in chronic kidney disease, interstitial kidney disease, acute kidney injury, and dialysis.

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Nephrology, 2005 - 2008
  • Tufts Medical Center
    Tufts Medical CenterResidency, Internal Medicine, 2002 - 2005
  • University of Texas Medical Branch
    University of Texas Medical BranchPhD, Pharmacology, 1994 - 1999
  • Weifang Medical University
    Weifang Medical University Class of 1989

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2006 - 2026
  • CT State Medical License
    CT State Medical License 2018 - 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Nephrology
    American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

  • Fellow (FASN) American Society of Nephrology

Publications & Presentations

PubMed

Journal Articles

  • Long‐Noncoding RNA Atrolnc‐1 Promotes Muscle Wasting in Mice with Chronic Kidney Disease  
    Sandhya S. Thomas, Yanlin Wang, Journal of Cachexia, Sarcopenia and Muscle

Press Mentions

  • Generation of Induced Pluripotent Stem Cell Line (ZZUi019-A) Derived from Skin Fibroblasts from a Healthy Volunteer
    Generation of Induced Pluripotent Stem Cell Line (ZZUi019-A) Derived from Skin Fibroblasts from a Healthy VolunteerMarch 12th, 2021
  • Generation of Induced Pluripotent Stem Cell Line (ZZUi0024-A) from a 51-Year-Old Patient with APP Gene Mutation in Alzheimer’ S Disease
    Generation of Induced Pluripotent Stem Cell Line (ZZUi0024-A) from a 51-Year-Old Patient with APP Gene Mutation in Alzheimer’ S DiseaseFebruary 24th, 2021
  • Generation of Induced Pluripotent Stem Cell Line (ZZUi0016-A) from Dermal Fibroblasts of a Normal Human
    Generation of Induced Pluripotent Stem Cell Line (ZZUi0016-A) from Dermal Fibroblasts of a Normal HumanJanuary 25th, 2020
  • Join now to see all

Grant Support

  • Novel mechanisms of kidney inflammation and fibrosisUNIVERSITY OF CONNECTICUT SCH OF MED/DNT2023–2026
  • Novel mechanisms of kidney inflammation and fibrosisUNIVERSITY OF CONNECTICUT SCH OF MED/DNT2023–2026
  • Targeting histone deacetylase 3 for chronic kidney diseaseVA CONNECTICUT HEALTHCARE SYSTEM2015–2025
  • Targeting histone deacetylase 3 for chronic kidney diseaseVA CONNECTICUT HEALTHCARE SYSTEM2015–2025
  • Targeting histone deacetylase 3 for chronic kidney diseaseVA CONNECTICUT HEALTHCARE SYSTEM2015–2025

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: